Harnessing the CRISPR‐Cas13d System for Protein Detection by Dual‐Aptamer‐Based Transcription Amplification
Chemistry – A European Journal · 2023
DOI: 10.1002/chem.202202693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Zhi-Yuan Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Cen…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Young Scientists Fund, Basic Research Program of Jiangsu Province.
Abstract (Originalsprache)
CRISPR‐based biosensing technology has been emerging as a revolutionary diagnostic tool for many disease‐related biomarkers. In particular, RspCas13d, a newly identified RNA‐guided Cas13d ribonuclease derived from Ruminococcus sp., has shown great promise for accurate and sensitive detection of RNA due to its RNA sequence‐specific recognition and robust collateral trans ‐cleavage activity. However, its diagnostic utility is limited to detecting nucleic‐acid‐related biomarkers. To address this limitation, herein we present a proof‐of‐concept demonstration of a target‐responsive CRISPR‐Cas13d sensing system for protein biomarkers. This system was rationally designed by integrating a d ual‐ a ptamer‐based t ranscription a mplification s trategy with CRISPR‐Cas13d (DATAS‐Cas13d), in which the protein binding initiates in‐vitro RNA transcription followed by the activation of RspCas13d. Using a short fluorescent ssRNA as the signal reporter and cardiac troponin I (cTnI) as the model analyte, the DATAS‐Cas13d system showed a wide linear range, low detection limit, and high specificity for the detection of cTnI in buffer and human serum. Thanks to the facile integration of various bioreceptors into the DATAS‐Cas13d system, the method could be adapted to detecting a broad range of clinically relevant protein biomarkers, and thus broaden the medical applications of Cas13d‐based diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, P. R. China.
Förderung
- Young Scientists Fund
- Basic Research Program of Jiangsu Province
Zitieren
APA
Feng, Z. Y., Liu, R., Li, X., & Zhang, J. (2023). Harnessing the CRISPR‐Cas13d System for Protein Detection by Dual‐Aptamer‐Based Transcription Amplification. Chemistry – A European Journal. https://doi.org/10.1002/chem.202202693
Vancouver
Feng ZY, Liu R, Li X, Zhang J. Harnessing the CRISPR‐Cas13d System for Protein Detection by Dual‐Aptamer‐Based Transcription Amplification. Chemistry – A European Journal. 2023. doi:10.1002/chem.202202693
BibTeX
@article{Feng2023,
author = {Feng, Zhi-Yuan and Liu, Ran and Li, Xiang and Zhang, Jingjing},
title = {Harnessing the CRISPR‐Cas13d System for Protein Detection by Dual‐Aptamer‐Based Transcription Amplification},
journal = {Chemistry – A European Journal},
year = {2023},
doi = {10.1002/chem.202202693}
}
EUVIMED